We hypothesized the existence of a mental GSK-3 disease, which comprises a specific group of patients associated with the GSK-3β variant, whose diagnoses longitudinally transition from depression to bipolar disorder and finally to dementia (16). This evidence concerns the gene GSK3B and major depressive disorder.